相关实验视频
Updated: Jun 21, 2026

08:50
Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
7.4K
单细胞转录组学揭示了垂体神经内分泌瘤中免疫表型的景观
Zhe Zhang1,2, Hong Su3, Jie Yin1,4
1Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China.
Chinese medical journal
|January 11, 2026
概括
下垂体瘤 (PitNETs) 显示出不同的免疫细胞模式. 皮特1系富含调节性T细胞 (Tregs) 和纤维细胞,在Tregs和巨细胞之间发现了一条新发现的CTLA4-CD86通路,影响瘤微环境.
科学领域:
- 内分泌学 在内分泌学.
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 免疫细胞显著影响垂体神经内分泌瘤 (PitNET) 的进展和治疗结果.
- 确切的免疫细胞组成和PitNETs中的功能动态尚未完全理解.
- 这项研究调查了PitNETs内的免疫异质性和细胞间通信.
研究的目的:
- 在不同的PitNET血统中划分免疫细胞异质性.
- 在PitNET瘤微环境 (TME) 中识别关键的细胞间通信网络.
- 用多种实验方法验证已识别的免疫相互作用.
主要方法:
- 单细胞RNA测序 (scRNA-seq) 在22个新鲜的PitNET样本上进行.
- 根据转录因子对PitNET进行分类:PIT1,SF1和TPIT.
- 细胞与细胞通信分析,多重免疫组织化学 (mIHC),流细胞计和体外共同培养试验被用于验证.
主要成果:
- 观察到显著的免疫细胞异质性,在PIT1,SF1和TPIT血统中具有明显的模式.
- 与癌症相关的纤维细胞 (CAF) 子集 (CAF3,CAF5) 和免疫细胞 (Tregs,Tfh) 显示出血统特定的丰富.
- 通过CTLA4-CD86通路调节的调节性T (Treg) 细胞和巨细胞之间的新型免疫抑制相互作用被确定并验证.
结论:
- 独特的免疫细胞频率是三个主要的PitNET血统的特征.
- 皮特1基因系特别富含Tregs,Tfh细胞和CAF3.
- CTLA4-CD86通路代表了PitNET TME中的Treg细胞和巨细胞之间的新型免疫抑制机制.
相关概念视频
lncRNA - Long Non-coding RNAs
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

